Published By: Saurabh Verma
Last Updated: October 25, 2023, 17:57 IST
Thiruvananthapuram [Trivandrum], India
The virus pressure seen in Kerala was the Bangladesh variant, which has a excessive mortality price of round 70-90 per cent.
(Photo: ANI)
George revealed {that a} resolution had been taken by two nationwide and a Kerala authorities institute to develop monoclonal antibodies
The monoclonal antibodies that are the one therapy towards Nipah an infection will probably be developed indigenously to fight the lethal virus, Kerala Health Minister Veena George mentioned on Wednesday.
George revealed {that a} resolution had been taken by two nationwide and a Kerala authorities institute to develop monoclonal antibodies.
The Kerala authorities’s Institute of Advanced Virology, the Rajiv Gandhi Centre for Biotechnology (RGCB) and the National Institute of Virology in Pune can be concerned within the effort, she mentioned. The minister mentioned it was being thought-about to develop the antibodies utilizing the cells of sufferers who recovered from the virus which contaminated six individuals, of whom two died, in Kozhikode district of the state final month.
The minister mentioned the monoclonal antibodies have been presently being imported from Australia the place they’re made in accordance with the Nipah variant current there. “We need to manufacture it indigenously for the variant seen here,” she mentioned.
The virus pressure seen in Kerala was the Bangladesh variant, which has a excessive mortality price of round 70-90 per cent.
(This story has not been edited by News18 workers and is printed from a syndicated news company feed – PTI)
Saurabh VermaSaurabh Verma covers common, nationwide and worldwide day-to-day news for news18.com as a Senior Sub-editor. He keenly observes politics and loves …Read More
Source: www.news18.com
